(Total Views: 506)
Posted On: 07/16/2023 3:31:08 PM
Post# of 154115
yes - i read in a report by Bank Credit Analyst how quickly AI will change the entire drug development landscape - it mentioned a specific focus on cancer, saying it will be reduced significantly in the next 10 years based on expected advances.
On the NASH front, the huge number of new obesity drugs now hitting the market will cut the progression of fatty liver disease - great for the population, but will result in fewer patients with NASH.
The bottom line is that the clock is ticking - i really hope we find a new CEO fast, and get out of this holding pattern. i still believe in this drug, but we need a win, and relatively quickly.
On the NASH front, the huge number of new obesity drugs now hitting the market will cut the progression of fatty liver disease - great for the population, but will result in fewer patients with NASH.
The bottom line is that the clock is ticking - i really hope we find a new CEO fast, and get out of this holding pattern. i still believe in this drug, but we need a win, and relatively quickly.
(3)
(1)
